ArticleBMC pediatrics2026

Two birds, one BiTE: blinatumomab achieves concurrent B-ALL control and EBV clearance in post-HSCT patients: two cases report.

Yawei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.